Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Capsovision Inc (CV)

Capsovision Inc (CV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 321,811
  • Shares Outstanding, K 46,843
  • Annual Sales, $ 341,920 K
  • Annual Income, $ 20,950 K
  • EBIT $ -24 M
  • EBITDA $ -24 M
  • 60-Month Beta N/A
  • Price/Sales 24.57
  • Price/Cash Flow N/A
  • Price/Book 14.14

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.69 +46.48%
on 02/23/26
7.35 -6.53%
on 03/20/26
+2.19 (+46.79%)
since 02/20/26
3-Month
4.50 +52.67%
on 02/20/26
14.92 -53.95%
on 12/24/25
-6.36 (-48.07%)
since 12/19/25

Most Recent Stories

More News
CapsoVision Announces $14 Million Private Placement Financing

SARATOGA, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (the “Company”) (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule...

CV : 6.87 (+11.17%)
CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision to Participate in the 38th Annual ROTH Conference

- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 - SARATOGA, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical...

CV : 6.87 (+11.17%)
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus®

SARATOGA, Calif., Dec. 29, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference

SARATOGA, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision Reports Third Quarter 2025 Financial Results

SARATOGA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule

SARATOGA, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision Appoints David Garcia as Senior Vice President of Finance

SARATOGA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025

SARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)
CapsoVision to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

SARATOGA, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions,...

CV : 6.87 (+11.17%)

Business Summary

CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif.

See More

Key Turning Points

3rd Resistance Point 9.04
2nd Resistance Point 8.20
1st Resistance Point 7.53
Last Price 6.87
1st Support Level 6.02
2nd Support Level 5.18
3rd Support Level 4.51

See More

52-Week High 15.37
Fibonacci 61.8% 10.81
Fibonacci 50% 9.40
Fibonacci 38.2% 7.99
Last Price 6.87
52-Week Low 3.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.